
The investment validates demand for unified health‑management tools in high‑risk industries and positions MyC to become a critical infrastructure provider for global enterprises facing fragmented medical workflows.
The industrial and offshore sectors have long struggled with disjointed health‑management processes, relying on spreadsheets, paper logs and siloed software that cannot keep pace with regulatory demands. As safety standards tighten and remote workforces expand, companies need a single, secure repository for medical data that can operate offline and sync when connectivity returns. MyC’s SaaS platform fills this gap by marrying clinical expertise with robust cloud architecture, delivering real‑time visibility into employee health while automating pharmaceutical inventories and compliance reporting.
Beyond operational efficiency, MyC addresses a strategic risk management imperative. In high‑risk environments, rapid medical response can prevent costly downtime and legal exposure. By centralising health records and enabling specialist consultations across borders, the platform reduces response times and ensures consistent care standards. This capability is especially valuable for multinational firms that must navigate divergent health regulations, as MyC’s compliance engine aligns with international standards, simplifying audits and reducing administrative overhead.
The €10 million round signals strong investor confidence in the convergence of health tech and industrial digital transformation. With backing from Hi Inov and other European venture firms, MyC is poised to scale its sales force and accelerate feature development, targeting a broader segment of essential industries. As European regulators push for digitised occupational health solutions, MyC’s growth could set a new benchmark for secure, scalable medical operations in the most complex worksites.
Comments
Want to join the conversation?
Loading comments...